Detalhe da pesquisa
1.
Metabolic Communication by SGLT2 Inhibition.
Circulation
; 149(11): 860-884, 2024 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38152989
2.
Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32-week randomized trial.
Diabetes Obes Metab
; 26(5): 1624-1635, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240066
3.
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
Diabetologia
; 66(5): 813-825, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36746803
4.
Evaluation of renal oxygenation by BOLD-MRI in high-risk patients with type 2 diabetes and matched controls.
Nephrol Dial Transplant
; 38(3): 691-699, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35612982
5.
Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
Diabetologia
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739291
6.
The effects of semaglutide, empagliflozin and their combination on the kidney sodium signal from magnetic resonance imaging: A prespecified, secondary analysis from a randomized, clinical trial.
J Diabetes Complications
; 38(2): 108673, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38219335
7.
Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: A prespecified secondary analysis of a randomised clinical trial.
J Diabetes Complications
; 37(5): 108472, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062189
8.
Volumes of coronary plaque disease in relation to body mass index, waist circumference, truncal fat mass and epicardial adipose tissue in patients with type 2 diabetes mellitus and controls.
Diab Vasc Dis Res
; 16(4): 328-336, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30714400